reference/19022056

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19022056

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2449
issn	0923-7534
issueIdentifier	12
pageRange	2442-2449
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	2442
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9bd1f4fa92d1cfb16864f1251bc7c23a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b711ffdbe8af5c8f3f9c53da46d83fa http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1155fbb1f62b1ab85439cbe76d5bc386 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6d48ae7b8256a7902c7bbcb6f74c841
bibliographicCitation	Munzone E, Giobbie-Hurder A, Gusterson BA, Mallon E, Viale G, Thürlimann B, Ejlertsen B, MacGrogan G, Bibeau F, Lelkaitis G, Price KN, Gelber RD, Coates AS, Goldhirsch A, Colleoni M; International Breast Cancer Study Group and the BIG 1-98 Collaborative Group. Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. Ann Oncol. 2015 Dec;26(12):2442–9. PMID: 26387144; PMCID: PMC4658543.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a9804e614275dd33a2c5eabc60d23ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8c8b665d62ebd4020c5f31e5f03d7b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d43a40495ab471a4f68d2b860e62460 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6cf2b8a4c2f069dcce1337044da6fa6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a10d4393929de3faf7cd4e5efd7481bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a75f2973c78ecdd3698ddceb5cb20c64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96f67eb96a5e074639e273b1103be01a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4d464091bf0640601800d0d33c9e15c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_194988831025552183d468ef9e6868e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd5613a915fdbd046c8b6ec64f4c785e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef54e0b32b254653941990d973d6d6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51b33e4e6d851035669b95b8f3c73286 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db3989703bf693b9dfa4263e7dad5c1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d2005866a0f0a098b3464abee41b9fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9df83070563ec7ce8a4916d68f03b52
date	201512
identifier	https://doi.org/10.1093/annonc/mdv391 https://pubmed.ncbi.nlm.nih.gov/PMC4658543 https://pubmed.ncbi.nlm.nih.gov/26387144
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846 https://portal.issn.org/resource/ISSN/0923-7534
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
discusses	http://id.nlm.nih.gov/mesh/M0021024 http://id.nlm.nih.gov/mesh/M0028300 http://id.nlm.nih.gov/mesh/M000640349 http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0014878
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009570Q000008 http://id.nlm.nih.gov/mesh/D014230Q000008 http://id.nlm.nih.gov/mesh/D013629Q000008 http://id.nlm.nih.gov/mesh/D001943Q000175 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D018931Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018270Q000188 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000077289 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D018270Q000175 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D009364Q000175 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D017024
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 70.